Network-Based Analysis of Survival for Unresectable Hepatocellular Carcinoma

Seminars in Oncology

Volumn 37, Issue 2, 2010, Pages 170-181

  Pancoska, Petr ^a   Carr, Brian I ^b   Branch, Robert A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER SURVIVAL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENETIC HETEROGENEITY; HUMAN; LIVER CELL CARCINOMA; NETWORK LEARNING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX RATIO; SURVIVAL TIME;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MODELS, STATISTICAL; PROGNOSIS;

EID: 77952327844     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2010.03.008     Document Type: Article

References (24)

1. Carr B.I., Buch S.C., Kondragunta V., Pancoska P., and Branch R.A. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study. J Gastroenterol Hepatol 23 (2008) 1259-1266
2. El-Serag H.B., and Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132 (2007) 2557-2576
3. Johnson P.J., Melia W.M., Palmer M.K., Portmann B., and Williams R. Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma. Br J Cancer 44 (1981) 502-505
4. Okuda K., Ohtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56 (1985) 918-928
5. Carr B.I., Kondragunta V., Buch S.C., and Branch R.A. Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study. Cancer 116 (2010) 1305-1314
6. Carr B.I., Pancoska P., and Branch R.A. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study. Hepatol Int 4 (2009) 396-405
7. Sall J., Creighton L., and Lehman A. Start statistics: a guide to statistics and data analysis. Ch. 20 (2007), SAS Publishing, Cary, NC
8. Witten I.H., and Frank E. Data Mining: practical machine learning tools and techniques. Ch. 4. (ed. 2) (2005), Elsevier, New York
9. Matousek J., and Nesetril J. An invitation to discrete mathematics. (ed. 2) (2008), Oxford University Press, New York
10. Lee J.S., and Thorgeirsson S.S. Comparative and integrative functional genomics of HCC. Oncogene 25 (2006) 3801-3809
11. Thorgeirsson S.S., Lee J.S., and Grisham J.W. Functional genomics of hepatocellular carcinoma. Hepatology 43 Suppl 1 (2006) S145-S150
12. Woo H.G., Park E.S., Cheon J.H., et al. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma. Clin Cancer Res 14 (2008) 2056-2064
13. Woo H.G., Park E.S., Lee J.S., et al. Identification of potential driver genes in human liver carcinoma by genomewide screening. Cancer Res 69 (2009) 4059-4066
14. Furui J., Furukawa M., and Kanematsu T. The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma. Hepatogastroenterology 42 (1995) 445-449
15. Hamamura K., Shiratori Y., Shiina S., et al. Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein. Cancer 88 (2000) 1557-1564
16. Izumi M. Isolation, characterization and clinical evaluation of the gamma-glutamyltransferase associated with hepatocellular carcinoma. Acta Med Okayama 39 (1985) 19-33
17. Ju M.J., Qiu S.J., Fan J., et al. Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation. J Gastroenterol 44 (2009) 635-642
18. Moore S.W., Millar A.J., Hadley G.P., et al. Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence. Cancer 101 (2004) 642-649
19. Nomura F., Ohnishi K., and Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 64 (1989) 1700-1707
20. Rabe C., Pilz T., Klostermann C., et al. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 7 (2001) 208-215
21. Xu K., Meng X.Y., Wu J.W., et al. Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study. Am J Gastroenterol 87 (1992) 991-995
22. Yao D., Jiang D., Huang Z., et al. Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer 88 (2000) 761-769
23. Yao D.F., Huang Z.W., Chen S.Z., et al. Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyltransferase. Am J Clin Pathol 110 (1998) 743-749
24. Carr B.I., Pnacoska P., and Branch R.A. HCC in older patients. Dig Dis Sci (2010 Mar 18) Epub